Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Men's experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study.
Sutton E, Lane JA, Davis M, Walsh EI, Neal DE, Hamdy FC, Mason M, Staffurth J, Martin RM, Metcalfe C, Peters TJ, Donovan JL, Wade J; ProtecT Study Group. Sutton E, et al. Among authors: hamdy fc. Cancer Causes Control. 2021 Mar;32(3):261-269. doi: 10.1007/s10552-020-01380-3. Epub 2021 Jan 4. Cancer Causes Control. 2021. PMID: 33394204 Free PMC article.
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial.
Sanghera S, Mohiuddin S, Coast J, Garfield K, Noble S, Metcalfe C, Lane JA, Turner EL, Neal D, Hamdy FC, Martin RM, Donovan JL; ProtecT study group. Sanghera S, et al. Among authors: hamdy fc. BMC Cancer. 2020 Oct 7;20(1):971. doi: 10.1186/s12885-020-07276-4. BMC Cancer. 2020. PMID: 33028256 Free PMC article. Clinical Trial.
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study.
Donovan J, Hamdy F, Neal D, Peters T, Oliver S, Brindle L, Jewell D, Powell P, Gillatt D, Dedman D, Mills N, Smith M, Noble S, Lane A; ProtecT Study Group. Donovan J, et al. Health Technol Assess. 2003;7(14):1-88. doi: 10.3310/hta7140. Health Technol Assess. 2003. PMID: 12709289 Free article. Clinical Trial. No abstract available.
Prostate cancer: screening approaches.
Donovan JL, Martin RM, Neal DE, Hamdy FC. Donovan JL, et al. Among authors: hamdy fc. Br J Hosp Med (Lond). 2005 Nov;66(11):623-6. doi: 10.12968/hmed.2005.66.11.20023. Br J Hosp Med (Lond). 2005. PMID: 16308948 Review.
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
Catto JW, Robinson MC, Albertsen PC, Goepel JR, Abbod MF, Linkens DA, Davis M, Rosario DJ, Warren AY, Varma M, Griffiths DF, Grigor KM, Mayer NJ, Oxley JD, Deshmukh NS, Lane JA, Metcalfe C, Donovan JL, Neal DE, Hamdy FC; ProtecT study group. Catto JW, et al. Among authors: hamdy fc. Br J Cancer. 2011 Sep 27;105(7):931-7. doi: 10.1038/bjc.2011.314. Epub 2011 Aug 23. Br J Cancer. 2011. PMID: 21863028 Free PMC article. Clinical Trial.
467 results